Envomed

Company Overview

Snapshot

Founded in September 1999, Envomed operates with 1–10 employees. The company has secured one disclosed funding round and received a grant from Takeda in February 2024.

Business overview

Envomed develops an on-site medical waste treatment system for healthcare facilities, addressing environmental and health risks associated with traditional disposal methods like incineration and landfilling. Its core technology processes waste directly within healthcare facilities, neutralizing pathogens and reducing waste volume. This transforms hazardous medical waste into non-hazardous material for conventional disposal, thereby reducing environmental impact and lowering waste management costs for healthcare providers. The company operates within the Industrial Technologies sector, serving hospitals and laboratories across Asia, Europe, and Israel.

Strategic signal

In November 2023, Envomed's technology for on-site medical waste treatment was highlighted as a game-changer. This signals a growing recognition of the company's innovative approach to addressing critical environmental and health concerns in the healthcare industry, positioning it as a key player in sustainable waste management solutions.

Company Intelligence Q&A

What is Envomed's primary solution?

Envomed provides an on-site medical waste treatment system that processes waste directly within healthcare facilities, neutralizing pathogens and reducing waste volume to transform hazardous medical waste into non-hazardous material.

When was Envomed founded?

Envomed was founded in September 1999.

Which markets does Envomed serve?

Envomed serves geomarkets in Asia, Europe, and Israel.

What significant recognition did Envomed receive in late 2023?

In November 2023, Envomed's technology for treating medical waste on-site was recognized as a game-changing innovation by Haaretz.